Aldeyra Therapeutics, Inc. ALDX
Aldeyra Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 3,621,949 | $12.0M | 6.02% |
| AQR CAPITAL MANAGEMENT LLC | 3,751,558 | $8.0M | 6.24% |
| D. E. Shaw & Co., Inc. | 1,940,338 | $4.1M | 3.23% |
| RENAISSANCE TECHNOLOGIES LLC | 882,000 | $1.9M | 1.47% |
| CITADEL ADVISORS LLC | 542,744 | $1.2M | 0.9% |
| MILLENNIUM MANAGEMENT LLC | 360,350 | $767,546 | 0.6% |
| Point72 Asset Management, L.P. | 154,408 | $328,889 | 0.26% |
| TWO SIGMA INVESTMENTS, LP | 127,849 | $272,318 | 0.21% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.